Radical Addition of Perfluoroalkyl Iodides to Alkenes and Alkynes Initiated by Sodium Dithionite
(6-Chloro-3,3,4,4,5,5,6,6-octafluoro-1-iodohexyl)-
cyclohexane (3cd) 1H NMR (CDCl3, 400 MHz) δ:
0.78-0.85 (m, 1H), 1.05-1.45 (m, 5H), 1.62-1.90
(m, 5H), 2.77-2.89 (m, 2H), 4.34 (dt, J=10.4, 3.6 Hz,
1H); 19F NMR (CDCl3, 376 MHz) δ: −123.0 (t, J=12.0
Hz, 2F), −119.8 (dt, J=17.7, 15.0 Hz, 2F), −114.8 and
−112.7 (AB system, J=271.2 Hz, 2F), −68.1 (t, J=12.0
Hz, 2F); IR (neat) νmax: 2930, 2856, 1451, 1368, 1256,
1189, 1135, 972, 839, 746, 727, 704 cm−1; MS m/z
(relative intensity): 472 (M+, 0.14), 345 (100), 303
(60.83), 69 (12.89), 55 (23.85), 41 (8.9). HRMS calcd
for C12H14F8ClI 471.9701, found 471.9703.
1,1,2,2-Tetrafluoro-2-((1,1,2,2,3,3,4,4-octafluoro-
6-iodododecyl)oxy)ethanesulfonyl fluoride (3da) 1H
NMR (CDCl3, 400 MHz) δ: 0.88 (t, J=6.4 Hz, 3H),
1.20-1.46 (m, 8H), 1.69-1.87 (m, 2H), 2.68-2.99
(m, 2H), 4.27-4.36 (m, 1H); 19F NMR (CDCl3, 376
MHz) δ: −121.1-−120.8 (m, 2F), −119.8 (s, 2F),
−110.7 and −107.9 (AB system, J=268 Hz, 2F), −108.0
(s, 2F), −79.0-−78.8 (m, 2F), −77.9-−77.6 (m, 2F),
50.0 (s, 1F); IR (neat) νmax: 2960, 2932, 2860, 1465,
1355, 1322, 1211, 1150, 990, 820, 725, 609 cm−1; MS
m/z (relative intensity): 511 (24.61), 469 (47.73), 119
(100), 57 (82.03), 43 (39.08).
1,1,2,2-Tetrafluoro-2-((1,1,2,2,3,3,4,4-octafluoro-
6-iododecyl)oxy)ethanesulfonyl fluoride (3dg) 1H
NMR (CDCl3, 400 MHz) δ: 0.95 (t, J=7.2 Hz, 3H),
1.37-1.64 (m, 2H), 1.65-1.87 (m, 2H), 2.67-2.99
(m, 2H), 4.28-4.37 (m, 1H); 19F NMR (CDCl3, 376
MHz) δ: −121.0-−120.8 (m, 2F), −119.8 (s, 2F),
−110.6 and −108.1 (AB system, J=278 Hz, 2F), −108.2
(s, 2F), −79.0-−78.8 (m, 2F), −77.8-−77.6 (m, 2F),
50.1 (s, 1F); IR (neat) νmax: 2966, 2938, 2879, 1466,
1353, 1322, 1211, 1150, 991, 877, 821, 733, 650, 609
cm−1; MS m/z (relative intensity): 595 (M+, 0.06), 469
(100), 119 (83.85), 67 (28.36), 55 (15.07). HRMS calcd
for C11H10F13IO3S 595.9188, found 595.9184.
(29.71), 152 (26.68), 102 (30.81).
1,1,1,2,2,3,3,4,4-Nonafluoro-6-iodododec-5-ene
(5ab) 1H NMR (CDCl3, 400 MHz) δ: 0.89 (t, J=6.8
Hz, 3H), 1.24-1.38 (m, 6H), 1.52-1.63 (m, 2H), 2.58
-2.67 (m, 2H), 6.31 (t, J=14.8 Hz, 1H); 19F NMR
(CDCl3, 376 MHz) δ: −126.0-−125.9 (m, 2F), −124.4-
−124.3 (m, 2F), −105.8-−105.7 (m, 2F), −81.2 (t, J=
8.3 Hz, 3F); IR (neat) νmax: 2960, 2933, 2861, 1635,
1458, 1353, 1236, 1136, 1104, 1033, 881, 740, 695 cm−1;
MS m/z (relative intensity): 456 (1.68), 386 (27.62), 329
(15.76), 287 (19.27), 70 (25.82), 55 (22.24), 43 (100).
1-Fluoro-4-(3,3,4,4,5,5,6,6,6-nonafluoro-1-iodo-
hex-1-en-1-yl)benzene (5ac) 1H NMR (CDCl3, 400
MHz) δ: 6.60 (t, J=13.6 Hz, 1H), 7.02 (t, J=8.0 Hz,
2H), 7.28 (t, J=8.0 Hz, 2H); 19F NMR (CDCl3, 376
MHz) δ: −126.0-−125.8 (m, 2F), −123.9-−123.8 (m,
2F), −111.0-−110.9 (m, 1F), −105.5-−105.4 (m, 2F),
−81.1 (t, J=9.4 Hz, 3F); IR (neat) νmax: 2926, 1637,
1600, 1506, 1352, 1236, 1134, 1027, 892, 838, 750, 722
cm−1; HRMS calcd for C12H5F10I 465.9276, found
465.9272.
2-(3,3,4,4,5,5,6,6,6-Nonafluoro-1-iodohex-1-en-1-
yl)pyridine (5ad) 1H NMR (CDCl3, 400 MHz) δ: 6.67
(t, J=13.6 Hz, 1H), 7.21-7.25 (m, 1H), 7.31 (d, J=
8.0 Hz, 1H), 7.61-7.75 (m, 1H), 8.62-8.66 (m, 1H);
19F NMR (CDCl3, 376 MHz) δ: −126.0-−125.8 (m,
2F), −123.8-−123.6 (m, 2F), −106.2-−106.0 (m, 2F),
−81.0 (t, J=9.8 Hz, 3F); IR (neat) νmax: 3057, 2927,
2856, 1640, 1583, 1568, 1464, 1430, 1352, 1235, 1134,
1027, 874, 741, 695 cm−1.
(6-Chloro-3,3,4,4,5,5,6,6-octafluoro-1-iodohex-1-
en-1-yl)benzene (5ba) 1H NMR (CDCl3, 400 MHz) δ:
6.59 (t, J=13.6 Hz, 1H), 7.05-7.45 (m, 5H); 19F NMR
(CDCl3, 376 MHz) δ: −122.2-−122.2 (m, 2F), −119.8-
−119.5 (m, 2F), −105.5-−105.2 (m, 2F), −68.1 (t, J=
12.0 Hz, 2F); IR (neat) νmax: 3055, 2960, 1635, 1445,
1309, 1192, 1134, 977, 842, 778, 694, 672 cm−1.
1,1,2,2-Tetrafluoro-2-((1,1,2,2,3,3,4,4-octafluoro-
6-iodo-8-methylnonyl)oxy)ethanesulfonyl
fluoride
Acknowledgments
(3dh) 1H NMR (CDCl3, 400 MHz) δ: 0.87 (d, J=6.4
Hz, 3H), 0.97 (d, J=6.4 Hz, 3H), 1.34-1.44 (m, 1H),
1.75-1.99 (m, 2H), 2.67-3.42 (m, 2H), 4.23-4.32
(m, 1H); 19F NMR (CDCl3, 376 MHz) δ: −121.2-
−120.9 (m, 2F), −119.6 (s, 2F), −110.4 and −108.0 (AB
system, J=265 Hz, 2F), −108.2 (s, 2F), −79.1-−78.9
(m, 2F), −77.8-−77.6 (m, 2F), 50.0 (s, 1F); IR (neat)
νmax: 2962, 2876, 1463, 1389, 1354, 1321, 1208, 991,
877, 821, 741, 650, 609 cm−1; MS m/z (relative inten-
sity): 483 (100), 119 (64.21), 43 (67.39). HRMS calcd
for C12H12F13O3S (M−I) 483.0300, found 483.0302.
(3,3,4,4,5,5,6,6,6-Nonafluoro-1-iodohex-1-en-1-yl)-
benzene (5aa) 1H NMR (CDCl3, 400 MHz) δ: 6.58 (t,
J=13.6 Hz, 1H), 7.04-7.48 (m, 5H); 19F NMR (CDCl3,
376 MHz) δ: −125.9-−125.8 (m, 2F), −123.9-−123.7
(m, 2F), −105.8-−105.7 (m, 2F), −81.0 (t, J=8.3 Hz,
3F); IR (neat) νmax: 3063, 2927, 1636, 1489, 1445, 1352,
1235, 1134, 1028, 888, 756, 695, 591 cm−1; MS m/z
(relative intensity): 448 (M+, 1.67), 321 (100), 182
We are grateful for the financial support from the
973 Program of China (No. 2012CB821600), the Na-
tional Natural Science Foundation of China (Nos.
21172241, 21032006) and the Science and Technology
Commission
of
Shanghai
Municipality
(No.
11ZR1445700).
References
[1] Chambers, R. D. Fluorine in Organic Chemistry, Blackwell Pub-
lishing Ltd./CRC Press, Boca Raton, FL, 2004.
[2] Ojima, I. Flourine in Medicinal Chemistry and Chemical Biology,
Wiley, Chichester, U. K., 2009.
[3] Hiyama, T. Organofluorine Compounds, Chemistry and Applications,
Springer-Verlag, Berlin, 2000.
[4] Kirsch, P. Modern Fluoroorganic Chemistry, Wiley-VCH, Weinheim,
2004.
[5] Uneyama, K. Organofluorine Chemistry, Blackwell Publishing, Ox-
ford, 2006.
[6] Begue, J. P.; Bonnet-Delpon, D. Bioorganic and Medical Chemistry
Chin. J. Chem. 2013, 31, 939—944
© 2013 SIOC, CAS, Shanghai, & WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim
943